We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ovary Removal Linked to Increased Heart Disease

By HospiMedica International staff writers
Posted on 23 Feb 2017
Researchers at the University of Warwick and the NHS Foundation Trust, University Hospitals Birmingham conducted a nationwide retrospective study of the English Hospital Episode Statistics database to look for associations between removal of all ovarian tissue, versus conservation of at least one ovary at the time of hysterectomy with important health outcomes, such as ischemic heart disease, cancer, and all-cause mortality. More...
The study included 113,679 women aged 35-45 who had had a hysterectomy for benign conditions between April 2004 and March 2014.

The results showed that patients in the ovarian conservation group were less likely to be admitted for ischemic heart disease after hysterectomy, and they were also less likely to have a cancer related post-hysterectomy admission. A significant difference in mortality was also seen; 0.6% in those with ovarian conservation, compared to 1.01% in patients with bilateral removal. In addition, fewer deaths were related specifically to heart disease and to cancer. The study was published on February 6, 2017, in BMJ.

“The combination of biological plausibility and the massive 'effect size' make a compelling case that women can be advised that their risk of ovarian cancer is greatly reduced by surgical removal of both ovaries,” said lead author Professor Richard Lilford, MD, of the University ofWarwick Medical School. “However, the lifetime risk of developing ovarian cancer is one in 52 in the UK, and the removal of a metabolically active organ such as the ovary may have harmful effects in the long term.”

Hysterectomy, or surgical removal of the uterus, is one of the most common surgical procedures for women. It may be total--removal of the body, fundus, and cervix of the uterus--or supracervical, involving the removal of the uterine body while leaving the cervix intact. Over 600,000 hysterectomies are performed annually in the United States alone, 90% of which for benign conditions. Such rates (the highest in the industrialized world), have led to a controversy claiming that hysterectomies are being largely performed for unwarranted and unnecessary reasons.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.